Gray Darryl T, Veenstra David L
Department of Community Research and Community Education, The Hope Heart Institute, Seattle, Wash, USA.
J Thorac Cardiovasc Surg. 2003 Mar;125(3):618-24. doi: 10.1067/mtc.2003.14.
This study was undertaken to assess the degree to which published cost comparisons of minimally invasive direct coronary artery bypass through a thoracotomy versus conventional coronary artery bypass grafting, off-pump bypass surgery through a sternotomy, or angioplasty with or without stenting adhered to existing guidelines for performing economic analyses.
We used minimally invasive direct coronary artery bypass (MIDCAB), off-pump bypass surgery, cost-effectiveness, economic analysis, and related keywords to search MEDLINE, other literature databases and article reference lists for English-language economic analyses of minimally invasive direct coronary artery bypass procedures versus other procedures that were published from 1990 to February 2002. We critically appraised article adherence to a 10-item methodologic checklist modified to address issues particularly relevant to minimally invasive direct coronary artery bypass evaluations. Assessment discordance was reconciled by consensus.
Ten articles published from June 1997 to March 2001 compared costs and (generally) outcomes of minimally invasive direct coronary artery bypass with those of other procedures. All were nonrandomized comparisons, generally of concurrent intrainstitutional clinical series. Stated results generally favored minimally invasive direct coronary artery bypass, angioplasty, or off-pump bypass surgery through a sternotomy relative to conventional coronary artery bypass grafting. Studies adequately addressed an average of only 24% of applicable checklist items (range 0%-67%). Few studies adequately ensured the comparability of treatment groups, clearly performed intent-to-treat analyses, comprehensively and credibly measured costs that were considered, or clearly addressed costs and results of preprocedural angiography or postprocedural imaging. Only 1 study compared success of revascularization between minimally invasive direct coronary artery bypass and competing alternatives. No studies specified the cost-analysis perspective or included costs of physician or physician assistant care.
Most published comparative economic analyses of minimally invasive direct coronary artery bypass have failed to adequately address issues crucial to such evaluations. Future studies should more closely follow well-described principles of clinical epidemiology and cost-effectiveness analysis.
本研究旨在评估已发表的关于经胸廓切开术的微创直接冠状动脉旁路移植术与传统冠状动脉旁路移植术、经胸骨切开的非体外循环旁路手术或有或无支架置入的血管成形术之间成本比较,在何种程度上遵循了现行的经济分析指南。
我们使用微创直接冠状动脉旁路移植术(MIDCAB)、非体外循环旁路手术、成本效益、经济分析及相关关键词检索MEDLINE、其他文献数据库和文章参考文献列表,以查找1990年至2002年2月发表的关于微创直接冠状动脉旁路移植术与其他手术的英文经济分析文献。我们严格评估文章对一份经过修改的包含10项内容的方法学清单的遵循情况,该清单旨在解决与微创直接冠状动脉旁路移植术评估特别相关的问题。评估分歧通过协商一致解决。
1997年6月至2001年3月发表的10篇文章比较了微创直接冠状动脉旁路移植术与其他手术的成本及(通常)结果。所有研究均为非随机比较,通常是同一机构内的同期临床系列研究。所述结果总体上表明,相对于传统冠状动脉旁路移植术,微创直接冠状动脉旁路移植术、血管成形术或经胸骨切开的非体外循环旁路手术更具优势。研究平均仅充分涉及了适用清单项目中的24%(范围为0% - 67%)。很少有研究充分确保治疗组具有可比性、明确进行意向性分析、全面且可靠地衡量所考虑的成本或明确涉及术前血管造影或术后成像的成本及结果。只有1项研究比较了微创直接冠状动脉旁路移植术与其他替代方法之间的血管再通成功率。没有研究明确成本分析视角或纳入医生或医师助理护理的成本。
大多数已发表的关于微创直接冠状动脉旁路移植术的比较经济分析未能充分解决此类评估至关重要的问题。未来的研究应更严格地遵循临床流行病学和成本效益分析的详细原则。